Penile fibrosis is the buildup of scar tissue within the penis, most commonly in the tunica albuginea (the tough sheath surrounding the erectile chambers) or within the erectile tissue itself. The most recognized form is Peyronie’s disease, where fibrous plaques cause curvature, pain, and sometimes erectile problems. A broader category of corporal fibrosis can develop from prolonged priapism, penile surgery, chronic injection therapy, or systemic conditions like diabetes, and tends to present primarily as erectile dysfunction rather than visible deformity. Though the causes differ, both share a core problem: normal elastic tissue gets replaced by stiff scar tissue that interferes with how the penis functions.
What Causes Penile Fibrosis
The single most discussed trigger is repeated small-scale trauma to the tunica albuginea during sexual activity or other physical stress. Animal research has shown that repeated injuries to this tissue layer lead to fibrous plaques, broken elastic fibers, and increased expression of the proteins that drive scar formation, particularly a growth factor called TGF-β1.1Karger. Repeated Micro-Trauma of the Penile Tunica Albuginea: A New Animal Model of Peyronie’s Disease The prevailing theory is that the body’s wound-healing response goes into overdrive: instead of resolving normally, inflammation keeps cycling, laying down collagen until a hard plaque forms. Not everyone who experiences penile trauma develops fibrosis, though, which points to genetics and underlying health as major co-factors.
Genetic predisposition plays a real role. Men with Peyronie’s disease are more likely to also have Dupuytren’s disease, a fibrotic condition of the hand, suggesting a shared tendency toward abnormal scar formation. Researchers have identified chromosomal abnormalities and specific gene variations linked to fibrotic conditions in both tissues.2Sexual Medicine Reviews. The Genetic Basis of Peyronie Disease: A Review If you have a close relative with Dupuytren’s or Peyronie’s, your own risk is elevated.
Beyond trauma and genetics, corporal fibrosis can stem from a wide range of medical scenarios. Removal of an infected penile implant, severe penile injury, prolonged low-flow priapism (an erection that won’t resolve), and chronic injection of erectile-dysfunction medications directly into the penis can all cause it. Fibrosis presenting mainly as erectile dysfunction also develops in chronic smokers, heavy drinkers, men with poorly controlled high blood pressure or diabetes, and after radical prostatectomy for prostate cancer.3Sexual Medicine Reviews. Pathophysiology and Grayscale Ultrasonography of Penile Corporal Fibrosis In these cases, chronic poor blood flow and oxygen deprivation gradually replace healthy smooth muscle with fibrous tissue.
Symptoms and How the Condition Progresses
What you notice first depends on whether the fibrosis is in the tunica (as in Peyronie’s disease) or deeper in the erectile bodies. With Peyronie’s, the hallmark signs are a palpable lump or hard area under the penile skin that you can feel when the penis is soft, and a visible curve, narrowing, or shortening when erect. Erections can be painful, and the deformity can range from a mild bend to an hourglass indentation that makes intercourse difficult or impossible.4PubMed Central. US Imaging in Peyronie’s Disease With corporal fibrosis that isn’t Peyronie’s, the main symptom is often erectile dysfunction without a prominent curve, because the scarring is more diffuse rather than concentrated in a discrete plaque.
Peyronie’s disease follows a two-phase pattern. The acute phase, typically lasting six to eighteen months, is when the plaque is still soft, pain is present, and the curvature may be getting worse. During this window, curvature worsens in roughly a fifth to half of men, stays the same in about a third to two-thirds, and actually improves on its own in a small minority. Pain tends to resolve on its own within twelve months for most men.5PubMed Central. Acute Phase Peyronie’s Disease: Where Do We Stand? After that, the disease enters the stable phase, where the plaque hardens (sometimes calcifying), pain fades, and the degree of curvature holds steady for at least three to six months.6PubMed Central. The Natural History of Peyronie’s Disease This distinction between phases matters because the timing determines which treatments are appropriate.
How Penile Fibrosis Is Diagnosed
A doctor can often diagnose Peyronie’s disease through a physical exam alone, feeling for plaques in the flaccid penis and asking you to describe or photograph the curvature during an erection. When more detail is needed, ultrasound is the standard imaging tool. Color duplex Doppler ultrasound, performed after an injection that triggers an erection, lets the clinician visualize blood flow, plaque location, and calcification, and simultaneously assess erectile function.7Journal of Ultrasound in Medicine. Penile Elastography Versus Penile Duplex Ultrasonography in Diagnosing Non‐Responders to Intracavernosal Injection Newer techniques like elastography, which maps tissue stiffness, are being explored to pick up fibrosis that standard ultrasound might miss.
MRI with a surface coil can provide even more information. In a study of 28 men, MRI not only revealed the size and location of fibrous plaques but also detected active inflammation within them, confirmed by tissue analysis. The degree of contrast enhancement on MRI correlated with how much inflammatory cell activity was present, which can help doctors determine whether the disease is still in its active phase.8PubMed. Peyronie’s disease: MR findings in 28 patients MRI is not routinely ordered for every case, but it becomes useful when treatment planning hinges on knowing whether inflammation is ongoing.
Non-Surgical Treatments
During the active phase, the goal is to slow or stop the scarring process, relieve pain, and prevent the curvature from worsening. Once the disease stabilizes, the goal shifts to correcting whatever deformity remains. Several non-surgical options exist, but the evidence behind them varies considerably.
Collagenase Injections
The most studied injectable treatment is collagenase clostridium histolyticum, an enzyme that breaks down the collagen in Peyronie’s plaques. Trials involving more than 1,500 patients have shown that it significantly reduces penile curvature and plaque hardness and improves quality of life.9PubMed Central. Collagenase Clostridium Histolyticum in the Treatment of Peyronie’s Disease: Review of a Minimally Invasive Treatment Option A typical course involves a series of injections given in pairs, spaced weeks apart, combined with manual modeling of the plaque between visits. It is worth knowing that the availability of this drug has fluctuated by country, and it comes with a small risk of serious side effects including penile fracture, so it should only be administered by a specialist familiar with the protocol.
Penile Traction Therapy
Traction devices apply a low, sustained stretch to the penis over weeks or months. Early studies suggested that traction could increase penile length and reduce curvature.10PubMed Central. Penile traction therapy for Peyronie’s disease-what’s the evidence? However, a more recent systematic review and meta-analysis found that while traction had a statistically meaningful effect on curvature, it did not significantly improve penile length or erectile function.11PubMed Central. The effect of penile traction device in men with Peyronie’s disease on penile curvature, penile length, and erectile dysfunction: a systematic review and meta-analysis Traction may be most useful as an add-on to other treatments, particularly before or after surgery, where it can help preserve length that might otherwise be lost.12Therapeutic Advances in Urology. The use of penile traction therapy in the management of Peyronie’s disease: current evidence and future prospects
Shockwave Therapy
Extracorporeal shockwave therapy (ESWT) delivers focused acoustic pulses to the plaque. The evidence here is mixed. A meta-analysis found that shockwave therapy could reduce plaque size and relieve pain, but it did not significantly reduce curvature or improve erectile function.13BMC Urology. Updated recommendations on the therapeutic role of extracorporeal shock wave therapy for peyronie’s disease: systematic review and meta-analysis The pain relief finding is somewhat undercut by the fact that pain from Peyronie’s disease usually resolves on its own within a year. A separate review made this point explicitly, noting that while the pain reduction is statistically real, shockwave therapy poses a substantial out-of-pocket cost for a benefit the disease’s natural course often delivers for free.14Sexual Medicine Reviews. Shockwave Therapy in the Treatment of Peyronie’s Disease For men whose primary complaint is persistent pain that has not resolved after 12 months, ESWT may still be worth discussing with a urologist, but it should not be expected to straighten the penis.
Oral Medications
Pentoxifylline, an oral drug that improves blood flow and has anti-fibrotic properties, has shown some promise. In one study, more than 90% of men taking pentoxifylline had stable or reduced calcium deposits in their plaques, compared with fewer than half of untreated men. Pentoxifylline users were also much less likely to report subjective worsening of their condition.15PubMed Central. Pentoxifylline treatment and penile calcifications in men with Peyronie’s disease Other oral agents like vitamin E and potassium para-aminobenzoate have been tried over the years, but the evidence supporting them is weak and inconsistent. Pentoxifylline is the most credible oral option, though it is typically used as part of a broader strategy rather than on its own.
When Surgery Becomes the Right Option
Surgery is reserved for men whose disease has stabilized (curvature unchanged for at least three to six months, no pain) and whose deformity is severe enough to prevent satisfactory intercourse or cause significant distress. There is no benefit to operating during the active phase, because the plaque is still evolving and new scarring after surgery is more likely. The surgical approach depends on the degree of curvature, penile length, and erectile function.
Plication Procedures
For men with moderate curvature and good erectile function, plication is the most common approach. The surgeon shortens the side of the penis opposite the plaque by placing sutures that pull the tunica taut, straightening the shaft. It is efficient, carries a low complication rate, and has become the preferred technique for straightforward cases.16PubMed Central. Peyronie’s penile plication In a study of 80 men, complete correction (residual curvature of 10 degrees or less) was achieved in about 86%, with roughly two-thirds reporting satisfaction afterward. Around 16% experienced some degree of erectile difficulty after surgery, and complications occurred in about 13%.17PubMed Central. Clinical outcomes of the tunica albuginea plication for patients with Peyronie’s disease: a bicentric retrospective analysis The main trade-off is some penile shortening, since the procedure works by making the longer side match the shorter side.
Grafting Procedures
When curvature exceeds about 60 degrees, the penis is already short, or there is an hourglass deformity, plication would sacrifice too much length. In these cases, surgeons cut into or partially remove the plaque and patch the gap with a graft.18PubMed Central. Grafting techniques for Peyronie’s disease Graft materials include tissue from the patient’s own body (such as a vein segment or tissue lining) and off-the-shelf biological materials derived from animal sources. A comparison of porcine dermal grafts and bovine pericardium grafts in 63 men found no significant differences in long-term outcomes for erectile function, curvature correction, or complications.19Andrology. Long‐term outcomes after plaque incision and grafting for Peyronie’s disease: comparison of porcine dermal and bovine pericardium grafts Grafting preserves more length than plication but carries a higher risk of new erectile dysfunction because the surgery is more extensive.
Penile Prosthesis
For men who have both severe fibrosis and erectile dysfunction that does not respond to medication, a penile implant may be the best single-step solution. In cases of extreme corporal fibrosis, where the erectile chambers are so scarred that a standard implant cannot be placed, surgeons have performed simultaneous total corporal reconstruction and prosthesis implantation.20The Journal of Sexual Medicine. Simultaneous Total Corporal Reconstruction and Implantation of a Penile Prosthesis in Patients with Erectile Dysfunction and Severe Fibrosis of the Corpora Cavernosa This is a complex surgery, but for men with severe scarring it can restore both rigidity and a functional shape. Guidelines support this combined approach for advanced corporal fibrosis where conservative options have failed.21PubMed Central. Treatments for fibrosis of the corpora cavernosa
The Psychological Weight of Penile Fibrosis
The physical symptoms get the most clinical attention, but the emotional toll is often what drives men to seek help in the first place. Studies have found that up to 81% of men with Peyronie’s disease report emotional difficulties, about half report clinically meaningful depression, and more than half report relationship problems caused by the condition.22The Journal of Sexual Medicine. Psychological Impact of Peyronie’s Disease: A Review Across the broader literature, rates of depression range from 12% to 62% and anxiety from 7% to 75%, depending on the study population and how the conditions were measured.23Andrologia. Psychological Impacts on Peyronie’s Disease and Its Treatments: A Narrative Review of Current Evidence
Qualitative research paints a vivid picture. Men have described themselves as “abnormal,” “ugly,” or “half a man.” Many report losing their sexual confidence entirely, withdrawing from intimacy, and feeling unable to discuss the condition with partners or even doctors.24PubMed Central. Psychological aspects of Peyronie’s disease The shame and isolation feed on themselves: the less a man talks about it, the more distorted his perception of the problem becomes, and the longer he delays treatment. If you recognize yourself in any of this, the most practical step is to see a urologist who specializes in the condition. The stigma is far worse than the clinical reality, and many men find that even being told the condition has a name and a treatment pathway brings meaningful relief.
Rehabilitation After Prostate Surgery
Radical prostatectomy for prostate cancer damages the nerves that control erections, and the resulting lack of blood flow and oxygenation can trigger fibrosis within the erectile tissue over time. This is why urologists increasingly recommend early penile rehabilitation after surgery, using some combination of erectile-dysfunction pills, vacuum erection devices, or low-dose injection therapy. The rationale is that maintaining periodic erections, even artificially induced ones, keeps blood and oxygen flowing through the erectile chambers and prevents the smooth muscle from being replaced by scar tissue. Animal and early clinical data support starting rehabilitation as soon as possible after the procedure rather than waiting months to see whether erections return on their own.25PubMed Central. Penile rehabilitation after radical prostatectomy: does it work? The evidence in humans is still evolving, and the optimal protocol has not been settled, but the underlying logic is sound: healthy tissue that gets regular blood flow is less likely to scar.
Experimental Approaches on the Horizon
Stem cell therapy represents one of the more intriguing experimental directions. Adipose-derived stem cells, harvested from a patient’s own fat tissue, have shown anti-fibrotic and anti-inflammatory effects in animal models of Peyronie’s disease. Multiple studies in rats, and preliminary work in human tissue, suggest these cells can reduce plaque formation and preserve erectile function.26PubMed Central. Advances in stem cell therapy for the treatment of Peyronie’s disease Clinical trials in humans are still in early stages, and it will be years before stem cell therapy could become a routine option. Other experimental avenues include gene therapy targeting the TGF-β1 pathway that drives scar formation, and platelet-rich plasma injections, though rigorous human data for these are even thinner. For now, the treatments described earlier remain the practical toolkit, but the research pipeline is active enough that the landscape could look meaningfully different within the next decade.